S. Edward Torres


Ed oversees Lilly Ventures and brings 28 years of pharmaceutical and venture capital experience to the team. Since co-founding Lilly Ventures in late 2001, he has led the investments in, and served on the boards of, several biotech companies including the Fund’s current investments in Coherus BioSciences (NASDAQ:CHRS), Innocrin Pharmaceuticals and Viamet Pharmaceuticals.

Prior to his role in Lilly Ventures, Ed had a diverse set of experiences throughout the domestic and international pharmaceutical businesses including operational finance, planning, M&A, business development, and global marketing roles.

Ed received a Bachelor of Arts from Creighton University and a Master of Business Administration from the University of Michigan’s Ross School of Business, where he was a Consortium Fellow.